Semax intranasal formulations are investigated for mucosal transport and central nervous system distribution through olfactory or trigeminal pathways.
For laboratory research use only. Not for human or veterinary use.
This is a liquid spray-format Semax product for laboratory and analytical research. The bottle contains 25 mg total Semax in 15 mL of solution.
Preclinical Semax research has examined BDNF and NGF expression and related neurotrophin signaling. These research themes do not establish a consumer benefit or an effect from this specific spray product.
| Total Content | Volume | Concentration | 0.1 mL | 0.2 mL | 0.4 mL | 1.0 mL |
|---|---|---|---|---|---|---|
| 25mg | 15mL | 1.67mg/mL | 0.17mg | 0.33mg | 0.67mg | 1.67mg |
Quantified to verify concentration within accepted labeled specification.
Assessed for peptide purity and absence of significant impurities by analytical methods.
Confirmed by analytical testing to match reference peptide characteristics.
Batch records and test data maintained for traceability and transparency.
Tested for potency, purity, and identity verification. COA generated for the current production batch.
Unreconstituted
Store at -20°C to 4°C (freezer or refrigerator). Stable for 24+ months.
Reconstituted
Refrigerate at 2–8°C. Use within 30 days for optimal stability.
Avoid
Repeated freeze-thaw cycles, direct sunlight, and temperatures above 25°C.
The bottle contains 25 mg total Semax in 15 mL, which equals approximately 1.67 mg/mL.
The amount per spray depends on the pump’s verified output volume. It can’t be determined from the total bottle content and volume alone.
Unreconstituted
Store at -20°C to 4°C (freezer or refrigerator). Stable for 24+ months.
Reconstituted
Refrigerate at 2–8°C. Use within 30 days for optimal stability.
Avoid
Repeated freeze-thaw cycles, direct sunlight, and temperatures above 25°C.
